So if that's considered, you know, a pertinent therapy based on everything we've talked about so far in this episode, right
For example, large language models trained on electronic health records or scientific literature (hosted on Roches GPUs) could identify new target indications or safety signals
Therefore, given the potential for increased risk of fat mass gain, persistent muscle loss, and declining physical capacity with weight cycling, coupled with evidence that the prevalence of sarcopenic obesity is estimated to be 20% in obese treatment-seeking adults [15], it is possible voluntary weight loss followed by involuntary regain may increase (or further exacerbate) the risk of sarcopenia and sarcopenic obesity, particularly in older adults
Warnings and Precautions: Allergies: Do not use ondansetron if you are allergic to it or similar medications
Decreased urine output or difficulty urinating, potentially signaling dehydration or kidney dysfunction Dark-colored or concentrated urine , which typically indicates dehydration, especially following gastrointestinal side effects Painful urination, urgency, or burning sensation , suggesting a possible urinary tract infection that may require antibiotics Blood in the urine (hematuria), which requires prompt evaluation regardless of other symptoms Foamy or frothy urine that persists, potentially indicating proteinuria or kidney disease Dehydration is a particular concern with semaglutide due to its gastrointestinal side effects
